Pharma Journalist -

Medexus Pharmaceuticals Inc. announced that it has entered into a licensing agreement with photonamic GmbH & Co. KG for the exclusive rights to market and distribute Gliolan in…
Read More...

Biogen announced that it has entered into an agreement to acquire Nightstar Therapeutics, a clinical-stage gene therapy company based in London, United Kingdom, which is focused on…
Read More...

Exclusive speaker interview released with Sumitomo Rubber ahead of Pre-filled Syringes West Coast 2019 In the run-up to Pre-Filled Syringes West Coast in June, SMi Group caught up…
Read More...

NantKwest and ProMab Biotechnologies announced the establishment of a worldwide license to a B-Cell Maturation Antigen (BCMA) targeted antibody sequence for multiple myeloma along with…
Read More...

SMi is delighted to present its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference, taking place in London on the 13th-14th May 2019. The global market for Highly…
Read More...

Apellis Pharmaceuticals announced a novel, risk-sharing collaboration to support the development of APL-2 in hematologic indications with SFJ Pharmaceuticals, a global drug development…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has approved Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) for subcutaneous (under the skin) injection for the…
Read More...

Pfenex Inc. and Alvogen Ltd. announced entering into agreements expanding their collaboration to develop and commercialize Pfenex’s lead product candidate, PF708, a proprietary…
Read More...

Third Rock Ventures announced the launch of Maze Therapeutics, a company focused on translating genetic insights into new medicines. The company has secured an initial investment…
Read More...

AbCellera announced an expanded collaboration with Denali Therapeutics Inc. to discover antibodies as therapies for neurological indications. AbCellera will generate panels of…
Read More...